Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03599349 · ClinicalTrials.gov registry record · NA
Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences
A NA study of Facial and Neck Skin Laxity, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03599349: Completed NA study of Facial and Neck Skin Laxity, sponsored by Ulthera.
NCT03599349 is a NA study of Facial and Neck Skin Laxity that has completed, run by Ulthera. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03599349, a NA study of Facial and Neck Skin Laxity, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluate if there is a correlation between efficacy results and where the Thermal Coagulation Points (TCPs) produced during a treatment with the Ulthera System make contact with anatomical layers of the skin and underlying tissues.
Primary Outcome
TCP = Thermal Coagulation Points. The average Superficial Musculo-Aponeurotic System (SMAS) depth in the eyebrow and lower face regions (cheeks, submental and submandibular) will be compared to quantitative measurement of lift in the eyebrow and submental/neck lift at day 90 post-treatment
Conditions Studied
Interventions
- DEVICE Microfocused ultrasound w/ visualization
Study Locations (1)
California
- Clinical Testing of Beverly Hills - Beverly Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-08-20 |
| Est. Completion | 2016-07-13 |
| Phase | NA |
What the finished NCT03599349 record still lists
NCT03599349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Facial and Neck Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Microfocused ultrasound w/ visualization is the first listed.
NCT03599349 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03599349 about?
NCT03599349 is a clinical study titled "Evaluation of the Ulthera® System and Efficacy Correlation to Morphological Differences". Evaluate if there is a correlation between efficacy results and where the Thermal Coagulation Points (TCPs) produced during a treatment with the Ulthera System make contact with anatomical layers of the skin and underlying tissues.
What is the current status of trial NCT03599349?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-08-20. Estimated completion is 2016-07-13.
What conditions does trial NCT03599349 study?
This clinical trial studies the following conditions: Facial and Neck Skin Laxity.
What interventions are being tested in trial NCT03599349?
The interventions under investigation include: Microfocused ultrasound w/ visualization (DEVICE).
Who is sponsoring clinical trial NCT03599349?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03599349 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial and Neck Skin Laxity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03599349's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI